Eliglustat is a glucosylceramide synthase inhibitor indicated for the long-term treatment of type 1 Gaucher disease in patients who are CYP2D6 extensive metabolizers, intermediate metabolizers , or poor metabolizers in treatment-naive and treatment-experi.
This report contains market size and forecasts of Eliglustat API in global, including the following market information:
Global Eliglustat API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Eliglustat API Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Eliglustat API companies in 2021 (%)
The global Eliglustat API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Eliglustat API include Tecoland, Liverpool Biopharma, Clearsynth, Pharmaffiliates, AR Life Sciences, Symphony Pharma Life Sciences, Zhejiang Ausun Pharmaceutical, CoreSyn and Cangzhou Enke Pharma Tech. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Eliglustat API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Eliglustat API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Eliglustat API Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Eliglustat API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Eliglustat API Market Segment Percentages, by Application, 2021 (%)
Research
Pharmaceutical
Global Eliglustat API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Eliglustat API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Eliglustat API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Eliglustat API revenues share in global market, 2021 (%)
Key companies Eliglustat API sales in global market, 2017-2022 (Estimated), (MT)
Key companies Eliglustat API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Tecoland
Liverpool Biopharma
Clearsynth
Pharmaffiliates
AR Life Sciences
Symphony Pharma Life Sciences
Zhejiang Ausun Pharmaceutical
CoreSyn
Cangzhou Enke Pharma Tech